On April 20, 2022, Rapid7 discovered vulnerabilities in two TCP/IP–enabled medical devices produced by Baxter Healthcare. The flaws, four in total, affected the company’s SIGMA Spectrum Infusion Pump ...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s notice ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International (NYSE: BAX) this week announced the results of a retrospective analysis of data from Sigma Spectrum Infusion System pumps that found 90 percent ...
Baxter International Inc. BAX recently announced the launch of comprehensive asset tracking solution DeviceVue. The solution will be used alongside the company’s proprietary pump system, Sigma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback